Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $75.3900 (-4.67%) ($70.6000 - $82.8600) on Wed. Mar. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.41% (three month average) | RSI | 40 | Latest Price | $75.3900(-4.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -4.1% a day on average for past five trading days. | Weekly Trend | LGND declines -13.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(58%) IWC(55%) XBI(55%) IWM(54%) | Factors Impacting LGND price | LGND will decline at least -2.705% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-13%) UUP(-5%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.705% (StdDev 5.41%) | Hourly BBV | 0 () | Intraday Trend | 3.8% | | | |
|
1 - 5 Day Possible Target | $60.41(-19.87%) | Resistance Level | $94.18 | 5 Day Moving Average | $76.29(-1.18%) | 10 Day Moving Average | $87.25(-13.59%) | 20 Day Moving Average | $94.18(-19.95%) | To recent high | -30.9% | To recent low | 19% | Market Cap | $1.212b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |